Jun 29, 2026 04:20PM
Jun 26, 2026 07:00AM
Jun 22, 2026 07:00AM
May 28, 2026 04:01PM
May 28, 2026 04:00PM
May 22, 2026 07:01AM
May 22, 2026 07:00AM Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss
May 21, 2026 05:02PM
May 21, 2026 05:01PM
May 18, 2026 03:46PM
May 5, 2026 07:01AM
May 5, 2026 07:00AM
Apr 30, 2026 02:49PM
Apr 29, 2026 04:21PM Regeneron Pharma (REGN) PT Lowered to $769 at Truist Securities
Apr 29, 2026 06:30AM
Apr 23, 2026 03:46PM
Apr 23, 2026 03:46PM
Apr 23, 2026 12:53PM
Apr 23, 2026 12:40PM
Apr 22, 2026 05:30PM
Apr 22, 2026 05:30PM Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
Apr 21, 2026 10:30AM
Apr 21, 2026 10:30AM
Apr 13, 2026 01:00AM
Apr 8, 2026 08:00AM
Apr 2, 2026 12:01PM
Apr 2, 2026 12:00PM
Mar 24, 2026 04:19AM Dupixent approved in Japan for bullous pemphigoid treatment
Mar 24, 2026 02:00AM
Mar 10, 2026 09:29PM
Mar 6, 2026 02:51AM
Mar 3, 2026 05:31PM
Feb 27, 2026 07:13AM
Feb 27, 2026 07:00AM
Feb 24, 2026 09:30AM FDA approves Dupixent for allergic fungal rhinosinusitis treatment
Feb 24, 2026 09:30AM
Feb 24, 2026 09:30AM
Feb 19, 2026 07:00AM
Feb 19, 2026 07:00AM
Feb 17, 2026 05:31PM
Feb 16, 2026 05:31PM
Feb 10, 2026 07:00AM Regeneron presents phase 3 data for cat and birch allergy antibody treatments
Feb 10, 2026 07:00AM
Feb 9, 2026 07:17AM
Feb 2, 2026 07:00AM
Feb 2, 2026 07:00AM
Dec 23, 2025 04:42AM
Dec 23, 2025 01:00AM
Dec 8, 2025 02:52AM Regeneron reports trial results for Lynozyfic in newly diagnosed myeloma
Dec 7, 2025 04:30PM

325,726 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All